Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Drug Screening Using Novel IMD in Salivary and Head and Neck Cancers — Stella

Home/Salivary Gland Cancer/Drug Screening Using Novel IMD in Salivary and Head and Neck Cancers

View on ClinicalTrials.gov

Recruiting

Back to Salivary Gland Cancer trials

Drug Screening Using Novel IMD in Salivary and Head and Neck Cancers

Early Phase 1 — Very small initial tests in humans, typically just a few people, to make sure the treatment is safe enough to study further.

Trial locations(2 sites)

United States

Brigham and Women's Hospital, Boston, Massachusetts

Dana Farber Cancer Institute, Boston, Massachusetts

Key details

Phase

Very early testing

Sponsor

Brigham and Women's Hospital

Collaborators

Adenoid Cystic Carcinoma Research Foundation

Enrollment target

~30 participants

Started

November 2023

Primary completion

April 2029

Age range

18 Years and older

Last updated January 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.